Sp63
THE PROMISE AND PITFALLS OF BRINGING NEW BARRETT'S TOOLS TO MARKET
Date
May 18, 2024
Presenter
University of North Carolina
Tracks
Related Products
‘INCIDENTAL’ BARRETT’S ESOPHAGUS IS ASSOCIATED WITH HIGH RATES OF NEOPLASIA AND LOW RATES OF ADHERENCE TO QUALITY INDICATORS: A POPULATION-BASED ANALYSIS USING THE GIQUIC NATIONAL QUALITY BENCHMARKING REGISTRY
‘Incidental’ BE, defined as BE diagnosed during exams for reasons other than BE screening or surveillance, has unknown incidence and outcomes. Patient characteristics, detection of dysplasia, and adherence to established quality indicators in this patient population has not been described…
DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)
Recent studies have described the durability of EET for BE-related neoplasia and the risk of neoplastic recurrence after achieving complete eradication of intestinal metaplasia (CE-IM). Current guidelines for endoscopic surveillance intervals post-EET are based on limited evidence…
